Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Carl Edward Sagan’s (1934-1996) one of the famous quotation was “Who are we? We find that we live on an insignificant planet of a humdrum star lost in a galaxy tucked away in some forgotten corner of a universe in which there are far more galaxies than people.“ From past to date, well-known molecules, enzymes, proteins, lipids and carbohydrates are studied in the pathogenesis of several diseases both as a diagnostic/prognostic biomarker and therapeutic agent. The underlying mechanism of unexplained diseases and failure of therapies are frequently studied with well-known biomarkers, but remain…mehr
Carl Edward Sagan’s (1934-1996) one of the famous quotation was “Who are we? We find that we live on an insignificant planet of a humdrum star lost in a galaxy tucked away in some forgotten corner of a universe in which there are far more galaxies than people.“ From past to date, well-known molecules, enzymes, proteins, lipids and carbohydrates are studied in the pathogenesis of several diseases both as a diagnostic/prognostic biomarker and therapeutic agent. The underlying mechanism of unexplained diseases and failure of therapies are frequently studied with well-known biomarkers, but remain unclear in many cases. As Dr. Sagan said other keys are still waiting to be known in some forgotten corner of a body universe, we find strength to propose that one of them can be the growth factor with cytokine activity named “Midkine” This book summarizes the extensive up-to-date literature overeview with the lastest work of experts about midkine in a detailed format that conveys its role as botha pathologic factor and therapeutic agent.
PART I: General aspects of mıdkıne.-1 General information on midkine.-2The role of midkine in neural development and patterning.-3Midkine- A player in innate immunity.-4 Midkine/p63 axis in regulation of epithelial-mesenchymal transition.-5 Immunochemical methods for the detection of midkine in samples of human origin.-6 Circulating midkine in malignant, inflammatory, and infectious diseases: a systematic review.II Mıdkıne and ınflammatıon.-7 Midkine in inflammation and inflammatory diseases.-8 Rheumatoid arthritis and midkin.III Mıdkıne and the cardıovascular system.-9 Midkine and heart failure.-10 Vascular restenosis and midkine.-11 The potential of MK through the renin-angiotensin system.IV Mıdkıne and the nervous system.-12 Midkine and Multiple sclerosis.-13 MK gene transfer in brain infarction.-14 Midkine in psychiatric and neurodegenerative diseases.V Mıdkıne and the urogenıtal system, reproductıon and agıng.-15 Role of midkine in nephrogenesis and kidney Disease.-16 Midkine, a factor promoting cytoplasmic maturation of oocytes.-17 Endometriosis may be promoted by midkine: possible involvement of ovarian follicles.-18 Stem cells and midkine.-19 Midkine in skeletal physiology.VI Mıdkıne and cancer.-20 Midkine and chemotherapy resistance in cancers.-21 A gene medicine with the midkine transcriptional regulation as new cancer therapeutics.-22 Midkine as a tumor shared antigen.-23 Midkine in prostate cancer.-24 Midkine is a potential therapeutic target of hepatocellular carcinoma.-25 Midkine in glioblastoma with the modulator role switching autophagy to cell death or cell survival.-26 Colon cancer and midkine.-27 Osteosarcoma and midkine.Index.
PART I: General aspects of midkine.-1 General information on midkine.-2The role of midkine in neural development and patterning.-3Midkine- A player in innate immunity.-4 Midkine/p63 axis in regulation of epithelial-mesenchymal transition.-5 Immunochemical methods for the detection of midkine in samples of human origin.-6 Circulating midkine in malignant, inflammatory, and infectious diseases: a systematic review.II Midkine and inflammation.-7 Midkine in inflammation and inflammatory diseases.-8 Rheumatoid arthritis and midkin.III Midkine and the cardiovascular system.-9 Midkine and heart failure.-10 Vascular restenosis and midkine.-11 The potential of MK through the renin-angiotensin system.IV Midkine and the nervous system.-12 Midkine and Multiple sclerosis.-13 MK gene transfer in brain infarction.-14 Midkine in psychiatric and neurodegenerative diseases.V Midkine and the urogenital system, reproduction and aging.-15 Role of midkine in nephrogenesis and kidney Disease.-16 Midkine, a factor promoting cytoplasmic maturation of oocytes.-17 Endometriosis may be promoted by midkine: possible involvement of ovarian follicles.-18 Stem cells and midkine.-19 Midkine in skeletal physiology.VI Midkine and cancer.-20 Midkine and chemotherapy resistance in cancers.-21 A gene medicine with the midkine transcriptional regulation as new cancer therapeutics.-22 Midkine as a tumor shared antigen.-23 Midkine in prostate cancer.-24 Midkine is a potential therapeutic target of hepatocellular carcinoma.-25 Midkine in glioblastoma with the modulator role switching autophagy to cell death or cell survival.-26 Colon cancer and midkine.-27 Osteosarcoma and midkine.Index.
PART I: General aspects of mıdkıne.-1 General information on midkine.-2The role of midkine in neural development and patterning.-3Midkine- A player in innate immunity.-4 Midkine/p63 axis in regulation of epithelial-mesenchymal transition.-5 Immunochemical methods for the detection of midkine in samples of human origin.-6 Circulating midkine in malignant, inflammatory, and infectious diseases: a systematic review.II Mıdkıne and ınflammatıon.-7 Midkine in inflammation and inflammatory diseases.-8 Rheumatoid arthritis and midkin.III Mıdkıne and the cardıovascular system.-9 Midkine and heart failure.-10 Vascular restenosis and midkine.-11 The potential of MK through the renin-angiotensin system.IV Mıdkıne and the nervous system.-12 Midkine and Multiple sclerosis.-13 MK gene transfer in brain infarction.-14 Midkine in psychiatric and neurodegenerative diseases.V Mıdkıne and the urogenıtal system, reproductıon and agıng.-15 Role of midkine in nephrogenesis and kidney Disease.-16 Midkine, a factor promoting cytoplasmic maturation of oocytes.-17 Endometriosis may be promoted by midkine: possible involvement of ovarian follicles.-18 Stem cells and midkine.-19 Midkine in skeletal physiology.VI Mıdkıne and cancer.-20 Midkine and chemotherapy resistance in cancers.-21 A gene medicine with the midkine transcriptional regulation as new cancer therapeutics.-22 Midkine as a tumor shared antigen.-23 Midkine in prostate cancer.-24 Midkine is a potential therapeutic target of hepatocellular carcinoma.-25 Midkine in glioblastoma with the modulator role switching autophagy to cell death or cell survival.-26 Colon cancer and midkine.-27 Osteosarcoma and midkine.Index.
PART I: General aspects of midkine.-1 General information on midkine.-2The role of midkine in neural development and patterning.-3Midkine- A player in innate immunity.-4 Midkine/p63 axis in regulation of epithelial-mesenchymal transition.-5 Immunochemical methods for the detection of midkine in samples of human origin.-6 Circulating midkine in malignant, inflammatory, and infectious diseases: a systematic review.II Midkine and inflammation.-7 Midkine in inflammation and inflammatory diseases.-8 Rheumatoid arthritis and midkin.III Midkine and the cardiovascular system.-9 Midkine and heart failure.-10 Vascular restenosis and midkine.-11 The potential of MK through the renin-angiotensin system.IV Midkine and the nervous system.-12 Midkine and Multiple sclerosis.-13 MK gene transfer in brain infarction.-14 Midkine in psychiatric and neurodegenerative diseases.V Midkine and the urogenital system, reproduction and aging.-15 Role of midkine in nephrogenesis and kidney Disease.-16 Midkine, a factor promoting cytoplasmic maturation of oocytes.-17 Endometriosis may be promoted by midkine: possible involvement of ovarian follicles.-18 Stem cells and midkine.-19 Midkine in skeletal physiology.VI Midkine and cancer.-20 Midkine and chemotherapy resistance in cancers.-21 A gene medicine with the midkine transcriptional regulation as new cancer therapeutics.-22 Midkine as a tumor shared antigen.-23 Midkine in prostate cancer.-24 Midkine is a potential therapeutic target of hepatocellular carcinoma.-25 Midkine in glioblastoma with the modulator role switching autophagy to cell death or cell survival.-26 Colon cancer and midkine.-27 Osteosarcoma and midkine.Index.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Shop der buecher.de GmbH & Co. KG i.I. Bürgermeister-Wegele-Str. 12, 86167 Augsburg Amtsgericht Augsburg HRA 13309